SE454842B - Komposition for anvendning vid oftalmologiska applikationer innehallande en vattenlosning av en hogmolekyler polymer och ett lost polymert fergemne - Google Patents
Komposition for anvendning vid oftalmologiska applikationer innehallande en vattenlosning av en hogmolekyler polymer och ett lost polymert fergemneInfo
- Publication number
- SE454842B SE454842B SE8405464A SE8405464A SE454842B SE 454842 B SE454842 B SE 454842B SE 8405464 A SE8405464 A SE 8405464A SE 8405464 A SE8405464 A SE 8405464A SE 454842 B SE454842 B SE 454842B
- Authority
- SE
- Sweden
- Prior art keywords
- molecular weight
- composition
- dye
- high molecular
- aqueous solution
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 22
- 239000007864 aqueous solution Substances 0.000 title claims description 5
- 229920006158 high molecular weight polymer Polymers 0.000 title claims description 4
- 239000000126 substance Substances 0.000 title description 8
- 229920002307 Dextran Polymers 0.000 claims description 15
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 11
- 229920002674 hyaluronan Polymers 0.000 claims description 11
- 229960003160 hyaluronic acid Drugs 0.000 claims description 11
- 229920000642 polymer Polymers 0.000 claims description 9
- 229920000609 methyl cellulose Polymers 0.000 claims description 6
- 239000001923 methylcellulose Substances 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 239000000975 dye Substances 0.000 description 30
- 239000000243 solution Substances 0.000 description 20
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 235000010981 methylcellulose Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229920002385 Sodium hyaluronate Polymers 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 229940089982 healon Drugs 0.000 description 4
- 229940010747 sodium hyaluronate Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- SJEYSFABYSGQBG-UHFFFAOYSA-M Patent blue Chemical compound [Na+].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=CC=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 SJEYSFABYSGQBG-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000002159 anterior chamber Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000000985 reactive dye Substances 0.000 description 2
- RTLULCVBFCRQKI-UHFFFAOYSA-N 1-amino-4-[3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-sulfoanilino]-9,10-dioxoanthracene-2-sulfonic acid Chemical compound C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S(O)(=O)=O)C=C1NC(C=1)=CC=C(S(O)(=O)=O)C=1NC1=NC(Cl)=NC(Cl)=N1 RTLULCVBFCRQKI-UHFFFAOYSA-N 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- RTNUTCOTGVKVBR-UHFFFAOYSA-N 4-chlorotriazine Chemical group ClC1=CC=NN=N1 RTNUTCOTGVKVBR-UHFFFAOYSA-N 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- -1 carboxy, hydroxy, propyl Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- YKCWQPZFAFZLBI-UHFFFAOYSA-N cibacron blue Chemical compound C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S(O)(=O)=O)C=C1NC(C=C1S(O)(=O)=O)=CC=C1NC(N=1)=NC(Cl)=NC=1NC1=CC=CC=C1S(O)(=O)=O YKCWQPZFAFZLBI-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940016052 sodium hyaluronate 10 mg/ml Drugs 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/26—Cellulose ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8405464A SE454842B (sv) | 1984-11-01 | 1984-11-01 | Komposition for anvendning vid oftalmologiska applikationer innehallande en vattenlosning av en hogmolekyler polymer och ett lost polymert fergemne |
| CA000493264A CA1256030A (en) | 1984-11-01 | 1985-10-18 | Composition for ophthalmological use |
| JP60504964A JPS62500720A (ja) | 1984-11-01 | 1985-10-23 | 眼科用組成物 |
| DE8585905444T DE3567374D1 (en) | 1984-11-01 | 1985-10-23 | Composition for ophthalmological use |
| EP85905444A EP0202257B1 (de) | 1984-11-01 | 1985-10-23 | Zusammensetzung für ophthalmologische verwendung |
| AU50164/85A AU5016485A (en) | 1984-11-01 | 1985-10-23 | Composition for ophthalmological use |
| PCT/SE1985/000410 WO1986002548A1 (en) | 1984-11-01 | 1985-10-23 | Composition for ophthalmological use |
| US06/878,832 US4764360A (en) | 1984-11-01 | 1985-10-23 | Composition for ophthalmological use |
| ES548369A ES8800605A1 (es) | 1984-11-01 | 1985-10-30 | Procedimiento para preparar una composicion coloeada de utilidad en cirugia ocular. |
| MX45085A MX450A (es) | 1984-11-01 | 1985-10-30 | Composicion fijadora y procedimiento para su preparacion. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8405464A SE454842B (sv) | 1984-11-01 | 1984-11-01 | Komposition for anvendning vid oftalmologiska applikationer innehallande en vattenlosning av en hogmolekyler polymer och ett lost polymert fergemne |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8405464D0 SE8405464D0 (sv) | 1984-11-01 |
| SE8405464L SE8405464L (sv) | 1986-05-02 |
| SE454842B true SE454842B (sv) | 1988-06-06 |
Family
ID=20357565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8405464A SE454842B (sv) | 1984-11-01 | 1984-11-01 | Komposition for anvendning vid oftalmologiska applikationer innehallande en vattenlosning av en hogmolekyler polymer och ett lost polymert fergemne |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4764360A (de) |
| EP (1) | EP0202257B1 (de) |
| JP (1) | JPS62500720A (de) |
| AU (1) | AU5016485A (de) |
| CA (1) | CA1256030A (de) |
| DE (1) | DE3567374D1 (de) |
| ES (1) | ES8800605A1 (de) |
| MX (1) | MX450A (de) |
| SE (1) | SE454842B (de) |
| WO (1) | WO1986002548A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5008102A (en) * | 1986-02-26 | 1991-04-16 | York Kenneth K | Biocompatible intraocular light-screening compositions and methods of intraocular light screening |
| JPH0739508B2 (ja) * | 1986-11-11 | 1995-05-01 | 株式会社林原生物化学研究所 | プルラン・ポリエチレングリコ−ル会合物とその製造方法並びに用途 |
| EP0307525A1 (de) * | 1987-09-18 | 1989-03-22 | Kenneth K. York | Bioverträgliche intraokulare Lichtschützende Mischung |
| US5323775A (en) * | 1991-09-13 | 1994-06-28 | Allergan, Inc. | Diagnostic method for determining precorneal retention time of ophthalmic formulations |
| EP1132065A1 (de) * | 2000-03-07 | 2001-09-12 | Gerrit Reinold Jacob Melles | Farbige visko-elastische Zusammensetzung |
| US20050031540A1 (en) * | 2001-11-20 | 2005-02-10 | Nielsen Per Julius | Visco dye |
| DE10255601C5 (de) | 2002-10-14 | 2017-10-19 | Fluoron Gmbh | Verwendung eines Triphenylmethanfarbstoffs zur Herstellung eines Färbemittels bei der Netzhaut- und Glaskörperchirurgie |
| US8802651B2 (en) * | 2004-06-30 | 2014-08-12 | Abbott Medical Optics Inc. | Hyaluronic acid in the enhancement of lens regeneration |
| US20080038316A1 (en) * | 2004-10-01 | 2008-02-14 | Wong Vernon G | Conveniently implantable sustained release drug compositions |
| US20070031482A1 (en) * | 2005-08-02 | 2007-02-08 | Ceramoptec Industries, Ind. | PDT treatment method for cellulites and cosmetic use |
| DE102008064065B9 (de) | 2008-12-19 | 2011-01-05 | Fluoron Gmbh | Farbstofflösung |
| DE102009037514A1 (de) | 2009-08-17 | 2011-03-10 | Dirk-Henning Dr. Menz | Wasserlösliche Polysaccharidether und ihre Verwendung |
| EP2392355A1 (de) * | 2010-06-03 | 2011-12-07 | Medical Technology Transfer Holding B.V. | Farbzusammensetzung |
| EP2371395A1 (de) * | 2010-04-01 | 2011-10-05 | Medical Technology Transfer Holding B.V. | Farbzusammensetzung |
| US9579401B2 (en) | 2010-04-01 | 2017-02-28 | Medical Technology Transfer Holding B.V. | Staining composition |
| GB2493568B (en) * | 2011-08-09 | 2018-08-29 | Zeiss Carl Meditec Ag | Opthalmologic composition comprising an aqueous solution of at least one viscoelastic polysaccharide |
| ITVR20120051A1 (it) * | 2012-03-20 | 2013-09-21 | Bbs Srl | Composizione colorata per uso in metodi chirurgici oftalmici |
| GB2501943B (en) * | 2012-05-10 | 2020-09-23 | Zeiss Carl Meditec Ag | Ophthalmic viscoelastic device |
| ITFI20130074A1 (it) * | 2013-04-03 | 2014-10-04 | Ambrosone Orazio | Soluzione acquosa di contrasto per rendere visibile mediante metodica fotografica il canale di schlemm e le vie di deflusso dell¿umore acqueo e metodo diagnostico che utilizza detta soluzione. |
| DE102014103512A1 (de) * | 2014-03-14 | 2015-09-17 | Carl Zeiss Meditec Ag | Injektor zur Injektion eines Operations-Hilfsfluids in ein Auge sowie Verfahren zum Erzeugen eines Operations-Hilfsfluids |
| CN105903088A (zh) * | 2015-12-14 | 2016-08-31 | 上海其胜生物制剂有限公司 | 一种具有选择性前囊染色功能的眼科粘弹剂的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1340517A (en) * | 1969-12-01 | 1973-12-12 | Burton Parsons Chemicals Inc | Ophthalmic solution |
| SU1091056A1 (ru) * | 1982-08-31 | 1984-05-07 | Московский научно-исследовательский институт микрохирургии глаза | Способ окраски гиалуроновой кислоты в ткан х глаза |
-
1984
- 1984-11-01 SE SE8405464A patent/SE454842B/sv not_active IP Right Cessation
-
1985
- 1985-10-18 CA CA000493264A patent/CA1256030A/en not_active Expired
- 1985-10-23 EP EP85905444A patent/EP0202257B1/de not_active Expired
- 1985-10-23 WO PCT/SE1985/000410 patent/WO1986002548A1/en active IP Right Grant
- 1985-10-23 AU AU50164/85A patent/AU5016485A/en not_active Abandoned
- 1985-10-23 JP JP60504964A patent/JPS62500720A/ja active Granted
- 1985-10-23 DE DE8585905444T patent/DE3567374D1/de not_active Expired
- 1985-10-23 US US06/878,832 patent/US4764360A/en not_active Expired - Lifetime
- 1985-10-30 ES ES548369A patent/ES8800605A1/es not_active Expired
- 1985-10-30 MX MX45085A patent/MX450A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US4764360A (en) | 1988-08-16 |
| CA1256030A (en) | 1989-06-20 |
| EP0202257B1 (de) | 1989-01-11 |
| JPH0588206B2 (de) | 1993-12-21 |
| EP0202257A1 (de) | 1986-11-26 |
| SE8405464D0 (sv) | 1984-11-01 |
| MX450A (es) | 1993-12-01 |
| DE3567374D1 (en) | 1989-02-16 |
| JPS62500720A (ja) | 1987-03-26 |
| ES548369A0 (es) | 1987-11-16 |
| SE8405464L (sv) | 1986-05-02 |
| AU5016485A (en) | 1986-05-15 |
| ES8800605A1 (es) | 1987-11-16 |
| WO1986002548A1 (en) | 1986-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE454842B (sv) | Komposition for anvendning vid oftalmologiska applikationer innehallande en vattenlosning av en hogmolekyler polymer och ett lost polymert fergemne | |
| Puchtler et al. | Methacarn (methanol-Carnoy) fixation: practical and theoretical considerations | |
| DE69125609T2 (de) | Wasserunlösliche Hyaluronsäureabkömmlinge | |
| BRPI0110312B1 (pt) | método para o preparo de colágeno bi-orientado, preparação de colágeno bi-orientado e matriz de colágeno bi-orientado fibrilar | |
| CN108025110A (zh) | 可注射大孔水凝胶 | |
| DE3486341T2 (de) | Derivate von Dextran mit antikoagulierenden und antikomplementären Eigenschaften, ihre Herstellung und ihre biologischen Anwendungen. | |
| JP2003055401A (ja) | 多官能性架橋剤によって架橋したグリコサミノグリカン−ポリカチオン複合体とその製造法 | |
| SU1295993A3 (ru) | Способ получени средства на основе производных 4-окси-2 @ -1,2-бензотиазин-3-карбоксамид-1,1-диоксида | |
| US4532267A (en) | Vision correction lens made from an aminopolysaccharide compound or an ether or ester thereof | |
| CN106334192B (zh) | 一种丝胶蛋白水凝胶及其制备方法和应用 | |
| WO2014081969A1 (en) | Compositions and methods for reducing oxidative damage | |
| CN105816476A (zh) | 含有能够促进角膜上皮再形成的粘膜粘附多糖的眼科组合物 | |
| US4309534A (en) | Renatured chitosan and process of making same | |
| CN113456514B (zh) | 一种含玻尿酸的头皮养护组合物及其制备方法和应用 | |
| DE68912238T2 (de) | Injektionslösungen. | |
| Cummings | Subunit basis of head configurational changes in T2 bacteriophage | |
| Figueroa et al. | Circular dichroism studies of copper (II)‐hyaluronic acid complexes in relation to conformation of the polymer | |
| Goodman et al. | Conformational aspects of polypeptide structure. XXVI. Azoaromatic side-chain effect from poly-Lp-(p'-hydroxyphenylazo) phenylalanine | |
| Jeyanthi et al. | Collagen-poly (Hema) hydrogels for the controlled release of anticancer drugs—preparation and characterization | |
| Raghunath et al. | Grafting of poly (vinyl pyrrolidone) onto gelatin and its application as synthetic plasma expander | |
| Maraini et al. | Changes in Weight and in Protein–Water Ratio of the Lens in Human Senile Cataracts | |
| CN107660198A (zh) | 特别地用于眼科手术的手术方法和用于染色蛋白质的染料分子和染料制备物 | |
| Dick et al. | A new method for direct detection of heparin on surface-modified intraocular lenses: A modification of Jaques’ toluidine blue staining method | |
| CN108855005A (zh) | 一种用于吸附染色剂的三元共混物及其制备方法 | |
| Drzymala et al. | Acid polysaccharide content of frog rod outer segments determined by metachromatic toluidine blue staining |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8405464-2 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |